Connect with Trudell Medical International
Get access to free patient resources including samples and demonstration kits, invitations to exclusive respiratory webinars, updates on the latest respiratory research and more.
For Healthcare Professionals
Scientific information and resources to help you support your patients.
Always prescribe a spacer with an MDI
When prescribing a metered dose inhaler, remember to include an AEROCHAMBER* brand of chambers for both children and adults. AEROCHAMBER* VHC is proven to deliver inhaler medication better than the inhaler alone.
Learn More
Help your Bronchiectasis Patients Clear their Way to Better Health
The AEROBIKA* OPEP device is clinically proven to help patients clear their airways1
1) Svenningsen S, et al. Academic Radiology. 2017;24(1):4-12.
Learn more
How to Select the Greenest Inhaler
Register now to learn how patient-centric strategies can help improve sustainability and reduce the impact of inhalers on the environment.
Register Now
Scientific & Performance Evidence
See the latest studies, research and related information.
Product Resources
View our product videos and download our how-to-use instructions, and counseling materials.
Educational Webinars
Learn more from experts in respiratory medicine about how to help your patients manage their diseases.
Speak to a Representative
Contact us to find how we can help you and your patients.
Our Innovative Products
Featured Clinical Studies
AEROCHAMBER PLUS* FLOW-VU* Chamber
Greater Lung Deposition with AEROCHAMBER* VHC + MDI
Metered dose inhalers are an ideal delivery system for many respiratory patients. When combined with a spacer, they offer a number of advantages over dry powder inhaler devices.
AEROBIKA* OPEP Device
Patients using the AEROBIKA* OPEP device had a 31% reduction in COPD/chronic bronchitis-related readmission within 30 days of the index hospitalization
A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months